Cargando…

Outcomes of Kidney Transplant Patients with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab: A Systematic Review and Meta-Analysis

Background: Kidney transplantation in patients with atypical hemolytic uremic syndrome (aHUS) is frequently complicated by recurrence, resulting in thrombotic microangiopathy in the renal allograft and graft loss. We aimed to assess the use of eculizumab in the prevention and treatment of aHUS recur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez Suarez, Maria L., Thongprayoon, Charat, Mao, Michael A., Leeaphorn, Napat, Bathini, Tarun, Cheungpasitporn, Wisit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679118/ https://www.ncbi.nlm.nih.gov/pubmed/31252541 http://dx.doi.org/10.3390/jcm8070919

Ejemplares similares

Subarachnoid Hemorrhage in Hospitalized Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease: A Nationwide Analysis
por: Cheungpasitporn, Wisit, et al.
Publicado: (2019)

Recent Advances and Clinical Outcomes of Kidney Transplantation
por: Thongprayoon, Charat, et al.
Publicado: (2020)

Promises of Big Data and Artificial Intelligence in Nephrology and Transplantation
por: Thongprayoon, Charat, et al.
Publicado: (2020)

Use of Machine Learning Consensus Clustering to Identify Distinct Subtypes of Kidney Transplant Recipients With DGF and Associated Outcomes
por: Jadlowiec, Caroline C., et al.
Publicado: (2022)

Serum Klotho in Living Kidney Donors and Kidney Transplant Recipients: A Meta-Analysis
por: Thongprayoon, Charat, et al.
Publicado: (2020)

Atypical Hemolytic Uremic Syndrome After Liver Transplant Treated With Eculizumab
por: Bhatti, Sundus, et al.
Publicado: (2020)

Proton pump inhibitors and adverse effects in kidney transplant recipients: A meta-analysis
por: Boonpheng, Boonphiphop, et al.
Publicado: (2019)

Incidence and Mortality of Renal Cell Carcinoma after Kidney Transplantation: A Meta-Analysis
por: Chewcharat, Api, et al.
Publicado: (2019)

Epidemiology of parvovirus B19 and anemia among kidney transplant recipients: A meta-analysis
por: Thongprayoon, Charat, et al.
Publicado: (2020)

Outcomes of kidney transplantation in patients with hepatitis B virus infection: A systematic review and meta-analysis
por: Thongprayoon, Charat, et al.
Publicado: (2018)

Distinct phenotypes of kidney transplant recipients aged 80 years or older in the USA by machine learning consensus clustering
por: Thongprayoon, Charat, et al.
Publicado: (2023)

Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome
por: Siedlecki, Andrew M., et al.
Publicado: (2018)

The Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection and Injury Status
por: Thongprayoon, Charat, et al.
Publicado: (2020)

A Case of Atypical Hemolytic Uremic Syndrome Successfully Treated with Eculizumab
por: Thajudeen, B., et al.
Publicado: (2013)

Atypical Hemolytic Uremic Syndrome and Chronic Ulcerative Colitis Treated with Eculizumab
por: Webb, Tennille N., et al.
Publicado: (2015)

Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
por: Palma, Lilian M Pereira, et al.
Publicado: (2016)

Atypical hemolytic uremic syndrome and eculizumab therapy in children
por: Kim, Seong Heon, et al.
Publicado: (2018)

Treatment of Atypical Hemolytic-Uremic Syndrome in the Era of Eculizumab
por: Ebrahem, Rawaa, et al.
Publicado: (2017)

Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
por: Gomes, Sara Madureira, et al.
Publicado: (2021)

The Importance of Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome
por: Santos, Mariana S, et al.
Publicado: (2022)

Long-term outcomes of the Atypical Hemolytic Uremic Syndrome after kidney transplantation treated with eculizumab as first choice
por: de Andrade, Luis Gustavo Modelli, et al.
Publicado: (2017)

Feature Importance of Acute Rejection among Black Kidney Transplant Recipients by Utilizing Random Forest Analysis: An Analysis of the UNOS Database
por: Thongprayoon, Charat, et al.
Publicado: (2021)

Efficacy and Safety of SGLT-2 Inhibitors for Treatment of Diabetes Mellitus among Kidney Transplant Patients: A Systematic Review and Meta-Analysis
por: Chewcharat, Api, et al.
Publicado: (2020)

Successful eculizumab treatment of recurrent postpartum atypical hemolytic uremic syndrome after kidney transplantation
por: Garlo, Katherine, et al.
Publicado: (2015)

Predicting Acute Kidney Injury after Cardiac Surgery by Machine Learning Approaches
por: Thongprayoon, Charat, et al.
Publicado: (2020)

Successful Renal Transplantation in a Patient with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab in China
por: Sun, Ze-Jia, et al.
Publicado: (2016)

Degree of Glomerulosclerosis in Procurement Kidney Biopsies from Marginal Donor Kidneys and Their Implications in Predicting Graft Outcomes
por: Cheungpasitporn, Wisit, et al.
Publicado: (2020)

Acute Kidney Injury in Patients Undergoing Cardiac Transplantation: A Meta-Analysis
por: Thongprayoon, Charat, et al.
Publicado: (2019)

Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab
por: Andries, Gabriela, et al.
Publicado: (2017)

COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report
por: Cognard, Noëlle, et al.
Publicado: (2021)

Associations of new-onset atrial fibrillation and severe visual impairment in type 2 diabetes: A multicenter nationwide study
por: Kaewput, Wisit, et al.
Publicado: (2021)

Post-streptococcal glomerulonephritis associated with atypical hemolytic uremic syndrome: to treat or not to treat with eculizumab?
por: Kakajiwala, Aadil, et al.
Publicado: (2016)

Should eculizumab be discontinued in patients with atypical hemolytic uremic syndrome?
por: Rodriguez, Eva, et al.
Publicado: (2017)

Eculizumab in the Treatment of Gemcitabine-Induced Atypical Hemolytic Uremic Syndrome
por: Azad, Farhan, et al.
Publicado: (2023)

Eculizumab in the Treatment of Acetylcysteine-Induced Atypical Hemolytic Uremic Syndrome
por: Jalbert, Arielle, et al.
Publicado: (2023)

Clinical Phenotypes of Dual Kidney Transplant Recipients in the United States as Identified through Machine Learning Consensus Clustering
por: Tangpanithandee, Supawit, et al.
Publicado: (2022)

Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: A systematic review and meta-analysis
por: Boonpheng, Boonphiphop, et al.
Publicado: (2021)

Differences between Kidney Transplant Recipients from Deceased Donors with Diabetes Mellitus as Identified by Machine Learning Consensus Clustering
por: Thongprayoon, Charat, et al.
Publicado: (2023)

Machine Learning Consensus Clustering of Morbidly Obese Kidney Transplant Recipients in the United States
por: Thongprayoon, Charat, et al.
Publicado: (2022)

Activated Prothrombin Complex Concentrate-Induced Atypical Hemolytic Uremic Syndrome Treated with Eculizumab
por: Tsai, Hsin Hsiang Clarence, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_06qp0mbhbc5dl5h8aetgl5ncq4